CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net loss	$ (8,632,446)	$ (11,692,928)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	390,424	547,796
Loss on extinguishment of debt	1,260,399	0
Unrealized gain on change in fair value of senior secured convertible notes	(1,972,955)	0
Stock based compensation expense	1,129,110	1,356,351
Non-cash in process research and development	251,420	0
Amortization of debt issuance costs	23,828	1,479
Provision for bad debts	7,624	20,552
Change in operating assets and liabilities:
Accounts receivable	638,339	1,081,480
Inventories	78,740	105,099
Prepaid expenses, other current assets and deposits	23,767	(268,920)
Accounts payable and accrued liabilities	667,898	426,924
Deferred revenue	(727,920)	1,504,958
Net cash used in operating activities	(6,861,772)	(6,917,209)
Cash flows from investing activities:
Purchases of property and equipment	(67,438)	(266,008)
Net cash used in investing activities	(67,438)	(266,008)
Cash flows from financing activities:
Proceeds from secured convertible notes payable (including related parties of $550,000 and $1,185,000 for the years ended September 30, 2019 and 2018, respectively)	1,985,392	1,650,000
Net proceeds from sale of common stock and warrants	2,463,591	4,233,000
Net proceeds from private placement	402,381	0
Proceeds from exercise of warrants	987,501	0
Capitalized offering costs	(10,231)	0
Net cash provided by financing activities	5,828,634	5,883,000
Net decrease in cash and cash equivalents	(1,100,576)	(1,300,217)
Cash and cash equivalents at beginning of year	1,659,564	2,959,781
Cash and cash equivalents at end of year	558,988	1,659,564
Supplemental Disclosures of Cash Flow Information:
Cash paid during year for interest	0	0
Cash paid during year for income taxes	0	0
Non-cash investing and financing activities:
Public offering costs included in accounts payable and accrued liabilities	99,468	64,848
Deemed dividend-warrant repricing	309,607	0
Interest paid in kind (related party of $98,752)	126,980	0
Impact of adoption of new accounting pronouncements included in accumulated deficit	493,223	0
Warrants exercised cashlessly	100	0
Conversion of notes payable	$ 1,440,505	$ 0